The major safety concerns in the top-down approach include TB, opportunistic infections, neutralizing antidrug antibody formation, autoimmunity, malignancy, lymphoma, cardiovascular or ...

At the World Congress of Gastroenterology in September, I had the opportunity to debate the benefits of a 'top-down' approach to the treatment of Crohn's disease, beginning with biologic (anti ...